DaVita investigated by Justice
This article was originally published in The Gray Sheet
Executive Summary
Dialysis services firm will provide documents relating to medical director compensation, joint venture agreements with physicians and drug services to DoJ under a March 4 subpoena. The U.S. Attorney for the Eastern District of Missouri's investigation "significantly overlaps" with a similar action begun in February 2001 by the U.S. attorney in Philadelphia, the firm notes. DaVita acquisition target Gambro settled similar issues with the St. Louis attorney's office in December 2004 (1"The Gray Sheet" Dec. 13, 2004, p. 12)...
You may also be interested in...
Gambro Sale Of U.S. Dialysis Services Leaves $2 Bil. For Possible Acquisitions
Gambro's plan to refocus on its core renal and blood bank product offerings by divesting its U.S. dialysis services business provides about $2 bil. for potential acquisitions in related fields
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.